Navigation Links
Special Mouth Rinse Spots, Tracks Human Papillomavirus Infection
Date:10/31/2008

Study may lead to better diagnosis and monitoring for head/neck cancers

FRIDAY, Oct. 31 (HealthDay News) -- A simple mouth rinse can spot specific types of human papillomavirus, some of which cause genital warts and increase the risk of developing certain types of cancer, new research shows.

The study, published in the Nov. 1 issue of Clinical Cancer Research, reaffirms that people exposed to human papillomavirus (HPV-16), the variant that causes cervical cancer, are more likely to develop cancers of the head and neck.

The researchers followed 135 patients with head and neck cancer over five years, and found that the patients with HPV-16 positive tumors were far more likely to test positive for oral HPV-16 infections before, during, and after therapy.

Although past research has shown a strong association between cancers of the head and neck and HPV-16 infection, these researchers used genetic sequencing to confirm the link between HPV-16 infection and HPV-16 shed by tumors in patients with head and neck cancers. Patients with HPV-16 positive tumors were also more likely to test positive for all types of the virus.

"Most of the 50 percent of people who get an HPV infection at some point in their lives clear it with no problem," said study co-author Dr. Maura Gillison, an associate professor of oncology at Johns Hopkins. "The question is, how do we identify those who will have a problem from the infection with those who will not?"

Although the vaccine Gardasil has been shown to offer protection against HPV infection and thus reduce the incidence of cervical cancer, efforts to vaccinate young girls have been controversial. Some believe vaccinating young girls may encourage premarital sex or promote risky sexual behavior.

But the link between HPV infection and cancers of the head and neck has prompted many researchers to advocate vaccinating boys as well as girls. "In the future, vaccinating all young women between the ages of 9 and 26 would reduce oral cancer if HPV is indeed the cause," said Dr. Mark Werner, an obstetrician/gynecologist at William Beaumont Hospital in Royal Oak, Mich. "Maybe at some point, men or young boys will be vaccinated as well."

The study concluded that a noninvasive oral rinse may help researchers understand how different variants of the virus impact the development, outcome, and recurrence of different cancers.

"Can we use HPV oral detection for screening purposes to identify people who are at risk for this type of cancer?" asked Gillison. "The broader implications are that these can be applied to other studies."

More information

Find out more about HPV at the Centers for Disease Control and Prevention.



SOURCES: Mark Werner, M.D., obstetrician/gynecologist, William Beaumont Hospital, Royal Oak, Mich.; Maura Gillison, M.D., Ph.D., associate professor, oncology, Johns Hopkins University, Baltimore; Nov. 1, 2008, Clinical Cancer Research


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Specialty Retailers Sign Up to Sell Life Fitness Equipment
2. Animal Dermatology Clinic Announces Today the Grand Opening of a State of the Art Veterinary Specialty Practice in Pasadena, California
3. Obama Puts Healthcare, Economic Relief for Middle Class First in Prime-Time Special
4. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
5. Capella University Offers New MS in Psychology Specialization in Child and Adolescent Development : Capella is the only regionally accredited online university to offer this master's specialization
6. What Boomers Need to Know About Digestion; Enzymatic Therapy's CompleteGest1 Renew targets special digestive issues
7. Highly specialized, minimally invasive surgery for lung cancer allows patient to go home sooner
8. Highly-specialized, minimally-invasive surgery for lung cancer allows patient to go home sooner
9. Midwest NeuroSurgery & Spine Specialists Chooses Intergy EHR by Sage
10. Special Purpose Needles Market to Reach $3.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc
11. South Carolina Veterinary Specialists Installs State-of-the-Art Eklin Digital Practice(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Special Mouth Rinse Spots, Tracks Human Papillomavirus Infection
(Date:5/5/2016)... ... May 05, 2016 , ... Einstein Medical is ... to cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium and Congress, ... the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic ...
(Date:5/5/2016)... ... May 05, 2016 , ... Spring Fertility , the ... and with egg freezing, today announced the grand opening of its first location ... care, Spring Fertility offers both fertility preservation (egg, sperm, embryo, and testicular and ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Benefit Advisors (UBA), ... as the latest addition to its family of Partner Firms. Headquartered in Mount ... wellness, human resources, and health care consumerism specialists. , “Partnering with UBA will ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... commencement of a master charity program created to assist the people of their ... working closely with nonprofit organizations and community leaders. Their hope is to bring ...
(Date:5/5/2016)... ... 05, 2016 , ... Tim Dieter has announced the latest ... Dubuque, IA. The current campaign fundraises for Veteran’s Freedom Center on behalf of ... Freedom Center may now be made here: http://www.veteransfreedomcenter.com/donate/ . , Veteran’s Freedom ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Israel , May 4, 2016 ... today that BiondVax,s CEO, Dr. Ron Babecoff , will ... New York City . On Thursday, ... Pioneers 2016, a conference presented by Joseph Gunner ... The BiondVax presentation that Dr. Babecoff will be ...
(Date:5/4/2016)... Yissum Research Development Company of the ... had signed an exclusive world-wide licensing and research agreement ... degradation and immunomodulatory drugs for cancer and immune dysfunction, ... first-in-class therapy for hematologic and solid malignancies. Financial terms ... novel technology was developed by Yinon Ben-Neriah , ...
(Date:5/4/2016)... 4, 2016 Valeritas Holdings, Inc. ... alternative public offering (APO). This was accomplished via a ... Inc. and a private placement of approximately 5 million ... share. Under the terms of the reverse ... Holdings, Inc. will trade on the OTC Markets under ...
Breaking Medicine Technology: